Sign In
Buy IART
$16.10
+0.430 (+2.74%)
At Close: Jun 03, 2026
Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access
08:30am, Tuesday, 25'th Nov 2025
PRINCETON, N.J., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, commends the Centers for Medicare & Medicaid S
AXQ Capital LP Takes Position in Integra LifeSciences Holdings Corporation $IART
03:34am, Tuesday, 25'th Nov 2025
AXQ Capital LP bought a new position in shares of Integra LifeSciences Holdings Corporation (NASDAQ: IART) in the second quarter, according to the company in its most recent filing with the SEC. The f
PRINCETON, N.J., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, is pleased to announce the FDA 510(k) clearanc
Integra LifeSciences Holdings Corporation (IART) Q3 2025 Earnings Call Transcript
11:46am, Thursday, 30'th Oct 2025
Integra LifeSciences Holdings Corporation ( IART ) Q3 2025 Earnings Call October 30, 2025 8:30 AM EDT Company Participants Christopher Ward - Senior Director of Investor Relations Mojdeh Poul - Presid
Integra (IART) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
10:35am, Thursday, 30'th Oct 2025
While the top- and bottom-line numbers for Integra (IART) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compa
Integra LifeSciences (IART) Q3 Earnings Beat Estimates
08:11am, Thursday, 30'th Oct 2025
Integra LifeSciences (IART) came out with quarterly earnings of $0.54 per share, beating the Zacks Consensus Estimate of $0.43 per share. This compares to earnings of $0.41 per share a year ago.
Integra LifeSciences Reports Third Quarter 2025 Financial Results
06:00am, Thursday, 30'th Oct 2025
PRINCETON, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today reported financial results for the third
Integra LifeSciences to Host Third Quarter 2025 Financial Results Conference Call on October 30, 2025
08:30am, Wednesday, 15'th Oct 2025
PRINCETON, N.J., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, will release third quarter 2025 financial res
Integra LifeSciences to Spotlight Neurosurgical Product Portfolio at the Congress of Neurological Surgeons (CNS) Annual Meeting
08:30am, Wednesday, 08'th Oct 2025
Featuring Durepair® Dura Regeneration Matrix and Mayfield® Ghost™ Base Unit, Post Featuring Durepair® Dura Regeneration Matrix and Mayfield® Ghost™ Base Unit, Post
Integra LifeSciences Strengthens Leadership with Appointment of New Chief Medical Officer
08:30am, Monday, 22'nd Sep 2025
PRINCETON, N.J., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the appointment of Dr. Raymond Turner as its new corporate vice president an
Should You Continue to Hold Integra Stock in Your Portfolio Now?
11:40am, Tuesday, 16'th Sep 2025
IART shows strong demand in neurosurgery and Tissue Technologies but faces macro and liquidity challenges.
Integra LifeSciences Still Recovering From Self-Inflicted Wounds
03:05pm, Wednesday, 10'th Sep 2025
Integra LifeSciences remains deeply discounted due to ongoing operational setbacks, with the market adopting a cautious 'show me' stance until clear improvements emerge. Remediation and margin improve
Integra LifeSciences Holdings Corporation (IART) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
11:59am, Wednesday, 10'th Sep 2025
Integra LifeSciences Holdings Corporation (NASDAQ:IART ) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 8:30 AM EDT Company Participants Mojdeh Poul - President, CEO & Dire
Integra LifeSciences Leadership to Present at Wells Fargo and Morgan Stanley Healthcare Investor Conferences
04:30pm, Friday, 29'th Aug 2025
PRINCETON, N.J., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief executive officer M
Integra LifeSciences Holdings Corporation (IART) Q2 2025 Earnings Call Transcript
01:56pm, Friday, 01'st Aug 2025
Integra LifeSciences Holdings Corporation (NASDAQ:IART ) Q2 2025 Earnings Conference Call July 31, 2025 8:30 AM ET Executives Christopher Ward – Senior Director of Investor Relations Lea Daniels Kni
